Ruthenium arene complexes with mono-carbonyl analogues of curcumin as pendant or bridging ligands: Synthesis, anti-cancer activity and interaction with quadruplex DNA

Bi, Jiaming; Pay, Tianle; Wong, Zhen Xuan; Khong, Yan Yi; Kueh, Ming Xuan; Ng, Kai Jie; Lee, Peter Peng Foo; Tan, Yong Leng Kelvin

doi:10.1016/j.poly.2019.07.034

Cited by 8 publications

(1 citation statement)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[83] . To assess the cytotoxicity of the comparable ruthenium arene compounds 15a-b and 16a-b and the organic MAC entities 14a-b, the MTT assay was performed using the human acute lymphoblastic cell line MOLT-4 [87]. It was discovered that the anticancer efficacy of the ruthenium and MAC analogues, which comprised of the cyclopentanone moiety in their structural motif, rose by an order of magnitude as more organo-ruthenium centres were linked to the ligand [88].…”

Section: Figure 8: Monocarbonyl Curcumin Analogues With Cytotoxic Eff...mentioning

confidence: 99%

Recent Advances in C-5 Curcuminoids: Derivatives and Their Pharmacological Interventions.

Rautela1,

Suyal2,

Gairolla3

et al. 2023

ECB

View full text Add to dashboard Cite

Curcumin (Diferuloylmethane) a phenolic compound, an active component of turmeric, has been extensively explored for its wide range of biological activities due it its nontoxic nature even at high concentrations. It has been reported to demonstrate anti-inflammatory, antimalarial, anti-oxidant, anti osteoporosis, antibacterial, anti-fungal, anti-cancerous properties. This compound has excellent therapeutic potential but the facts which constrains its use as a therapeutic agent include poor stability in vivo, low bioavailability and high rate of metabolism. In vivo studies established the fact that curcumin gets degraded into inactive metabolites. Many modifications have been done in curcumin to improve drawbacks of natural curcumin among which one approach is to modify 7 carbon spacer (C-7) diketone moiety by 5 carbon spacer (C-5) moiety and preparing its open chain, homocyclic and heterocyclic analogues to study its implications on biological activities. The promising biological activities of such derivatives prompted medicinal chemists to further explore the possible modification in thrust to get lead molecule for further studies. The various modifications included symmetrical and unsymmetrical C-5 analogues. The modification was also done by preparing acyclic as well as cyclic analogues of C-5 curcumin including homocyclic and heterocyclic analogues. Promising and diverse biological activities of these derivatives further encouraged medicinal chemists to explore the molecule and elicit the therapeutic potential of molecules obtained. In current review exhaustive study of various methods to obtain such curcuminoids are reported along with the biological activity data of revamped molecules.

show abstract

Section: Figure 8: Monocarbonyl Curcumin Analogues With Cytotoxic Eff...mentioning

confidence: 99%